The solution to constipation you've been looking for: an alternative to enemas and laxatives. Developed by @usMIMA with the collaboration of @IGuttmann
📢This week MOWOOT CoFounder & CSO Dr. @IHerreroFresned presents the effectiveness of 'Intermittent Colonic Exoperistalsis' & the #MOWOOT device in patients with #constipation induced by medicine (MiC) at the United European Gastroenterology congress in Vienna. #UEGWeek@my_ueg
📣Good news: #MOWOOT has been selected as a finalist for the 'SilverEco & Ageing Well International Awards' @SilverEco_En taking place in Cannes on Sept. 16th 2024!
Please support us with your vote for the 'Public’s Choice Award' here: https://t.co/c9WptHxDU0
Today is #WorldMSDay!
➡ Multiple sclerosis (#MS) has many different symptoms, including bowel dysfunction.
➡ The majority (85%) of patients find most of these symptoms embarrassing.
It´s time to talk openly about bowel dysfunction & give them the support they need!
📢 ¡No te pierdas la oportunidad online de conocer a #MOWOOT y los detalles de nuestra ronda actual de #crowdfunding con @CapitalCellNet!
𝐇𝐨𝐲 𝐣𝐮𝐞𝐯𝐞𝐬, 9 𝐝𝐞 𝐦𝐚𝐲𝐨 𝐚 𝐥𝐚𝐬 18𝐡.
👉 Es necesaria la inscripción previa:
https://t.co/fKi5VnXOJu
¿Indeciso sobre una inversión en #MOWOOT a través de Capital Cell? Ven a ver nuestro CEO @rkusW presentar #MOWOOT en el #ConnectionDay24 de @CataloniaBioHT & @accio_cat.
📌 Mañana, martes 07.05.2025, a las 11h en el #Health#Investment Forum
👉https://t.co/dRHMTsRred
#ClienteEnisa@mowoot Más de 2 M€ de fondos europeos para conseguir la primera terapia eficaz que trate el síndrome del intestino irritable vía @isanidad
https://t.co/JyRpWWus0G
🔜 Next Tuesday, May 7th, we will participate in @CataloniaBioHT #ConnectionDay24.
🔎You can see our pitch at the #Health#Investment Forum organized by @accio_cat and/or schedule a meeting w/ our CEO @rkusW.
Register and book your meetings here:
👉 https://t.co/rZQjM4lLAw
📣 #LoMásLeído| 🗞️ #Actualidad| La start-up @mowoot lidera la investigación para el desarrollo de una plataforma digital para la monitorización y el tratamiento del síndrome del intestino irritable (SII)
#Sanidad#Médicos#ActualidadSanitaria
https://t.co/pE0slRM5GV
🌟 Exciting news! @mowoot secures €2M+ from Next Generation funds to develop a digital platform for managing Irritable Bowel Syndrome (IBS), supported by EIT Health. Learn more about MOWOOT's innovative IBS management: https://t.co/iuXHyeMvg1 #HealthTech#IBSManagement
📰ES: @isanidad dedica un articulo a nuestro proyecto de dar una solución al Síndrome del Intestino Irritable #SII.
📰EN_ @isanidad dedicates an article to our project to develop a solution for Irritable Bowel Syndrome #IBS.
https://t.co/At6enmp8em
📰 ES: "𝐏𝐚𝐫𝐚 𝐮𝐧 𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐨 𝐦𝐞𝐧𝐨𝐬 𝐢𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞" - Ayer en @LaVanguardia: nuestro proyecto del síndrome del intestino irritable #SII & nuestra ronda de inversión en @CapitalCellNet!
📰 EN: "𝐅𝐨𝐫 𝐚 𝐥𝐞𝐬𝐬 𝐢𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞 𝐛𝐨𝐰𝐞𝐥" #IBS in the news
💜 Today is #WorldIBSDay2024 & we announce that #MOWOOT has been granted a € 2,2 million publicly funded project to develop a novel #digital solution for Irritable Bowel Syndrome #IBS, in collaboration with @Eurecat_news & @IDIAPJGol! More info here👇
https://t.co/R4jyhBPYfZ
📢New #investment opportunity in #MOWOOT!
We are raising a bridge-funding round with @CapitalCellNet to support our international expansion & growth.
⌛Dont miss the 5% early-bird dicount!
More info here: https://t.co/95rcWgtLmM
💡What do #patients say about #MOWOOT, the non-drug & non-invasive solution to #constipation?
👩 Claudia has #SCI w/ spasticity since 1999 & was using drugs and laxatives to deal with the resulting bowel dysfunction.
👉 Discover #MOWOOT:
https://t.co/UBTp64p7hN
April is #IBSAwarenessMonth & we're raising awareness for the more than 35M Americans who have #IBS. IBS causes uncomfortable #GI symptoms and affects everyone differently. We have resources to help patients understand symptoms and treatment options: https://t.co/2lNmtnDIPH.